Join our community of smart investors

Indivior pays $600m in opioid marketing settlement

The group pleaded guilty to one count of making a false statement relating to healthcare matters in 2012
Indivior pays $600m in opioid marketing settlement

Shares in Indivior (INDV) are up by around two-thirds since early trading on Friday, after the pharma group revealed that it had agreed to resolve criminal charges and civil complaints in the US pertaining to opioid addiction treatment ‘Suboxone Film’.

IC TIP: Hold at 146p

To continue reading...
OR
Register for free
Read 3 articles for free each month
* Excl. premium articles
Have an account? Sign in